Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8864)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2021 (publication date) through May 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huang LL, Yu XP, Li JL, Lin HM, Kang NL, Jiang JJ, Zhu YY, Liu YR, Zeng DW. Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection. World J Gastroenterol 2021; 27(7): 641-653 [PMID: 33642834 DOI: 10.3748/wjg.v27.i7.641] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i7/641.htm |
| Number | Citing Articles |
| 1 |
Seyed Hamid Moosavy, Ebrahim Eftekhar, Parivash Davoodian, Abdolazim Nejatizadeh, Mohammad Shadman, Shahram Zare, Mirza Ali Nazarnezhad. AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02780-w
|
| 2 |
Fei-Xiang Xiong, Lei Sun, Xue-Jie Zhang, Jia-Liang Chen, Yang Zhou, Xiao-Min Ji, Pei-Pei Meng, Tong Wu, Xian-Bo Wang, Yi-Xin Hou. Machine learning-based models for advanced fibrosis in non-alcoholic steatohepatitis patients: A cohort study. World Journal of Gastroenterology 2025; 31(9): 101383 doi: 10.3748/wjg.v31.i9.101383
|
| 3 |
Shafei Liu, Conggao Peng, Shijia Xia, Chaonan Li, Xiahong Dai, Xingyu Liu, Meng Zhang, Xiaoping Li, Lingling Tang. Chitinase 3-like protein 1: a diagnostic biomarker for early liver fibrosis in autoimmune liver diseases. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1504066
|
| 4 |
Ruveena Bhavani Rajaram, Thevaraajan Jayaraman, Xin‐Hui Khoo, Nalliah Saravanaa, Anjanna Kukreja, Bushra Megat Johari, Nadia Fareeda Muhammad Gowdh, Wai‐Kin Lee, Choong‐Yeong Sooi, Sazali Basri, Rong‐Xiang Ng, Hang‐Cheng Ong, Pui‐Li Wong, Sharifah Faridah Syed Omar, Sanjiv Mahadeva. Liver dysfunction in adults with COVID‐19 infection: A longitudinal study with transient elastography evaluation. JGH Open 2024; 8(8) doi: 10.1002/jgh3.13118
|
| 5 |
Lilian Yan Liang, Terry Cheuk‐Fung Yip, Jimmy Che‐To Lai, Amy Shuk‐Man Lam, Yee‐Kit Tse, Vicki Wing‐Ki Hui, Henry Lik‐Yuen Chan, Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong. Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment. Journal of Viral Hepatitis 2024; 31(12): 808 doi: 10.1111/jvh.14004
|
| 6 |
Valentina Peta, Yuliya Sandler, Olivier Deckmyn, Oksana Duroselle, Elena Vinnitskaya, Sergey Khomeriki, Karina Noskova, Thierry Poynard. Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference. World Journal of Hepatology 2025; 17(3): 104534 doi: 10.4254/wjh.v17.i3.104534
Abstract(124) |
Core Tip(109) |
Full Article(HTML)(433)
|
Full Article with Cover (PDF)-1606K(22)
|
Audio-665K(0)
|
Peer-Review Report-221K(20)
|
Answering Reviewers-336K(30)
|
Supplementary Material-182K(15)
|
Full Article (PDF)-1322K(32)
|
Full Article (XML)-156K(26)
|
Times Cited (0)
|
Total Visits (1321)
|
Open
|
| 7 |
Andres Duarte-Rojo, Bachir Taouli, Daniel H. Leung, Deborah Levine, Tarek Nayfeh, Bashar Hasan, Yahya Alsawaf, Samer Saadi, Abdul Mounaem Majzoub, Apostolos Manolopoulos, Samir Haffar, Ayca Dundar, M. Hassan Murad, Don C. Rockey, Mouaz Alsawas, Richard K. Sterling. Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology 2025; 81(2): 725 doi: 10.1097/HEP.0000000000000852
|
| 8 |
Feng Chen, Qianhui Li, Xiaomin Xu, Fei Wang. Non-invasive Diagnostic Indicators and Antiviral Treatment Efficacy in CHB Patients with Different Liver Histopathological Degrees. Hepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-147016
|
| 9 |
Maria Guido, Alessandra Mangia, Neil D. Theise. MacSween's Pathology of the Liver. 2024; : 402 doi: 10.1016/B978-0-7020-8228-3.00006-5
|
| 10 |
Haiyan Fu, Hongjuan Li, Yingrong Du, Chunyun Liu, Futao Dang, Xuan Zhang, Danqing Xu, Yachao Mao, Li Feng Wang, Yu Luo, Li Liu. Factors influencing pathological changes in the liver tissue in hepatitis B virus carriers with low-level viremia. Clinics and Research in Hepatology and Gastroenterology 2024; 48(7): 102351 doi: 10.1016/j.clinre.2024.102351
|
| 11 |
Purva Gopal, Xiaobang Hu, Marie E. Robert, Xuchen Zhang. The evolving role of liver biopsy: Current applications and future prospects. Hepatology Communications 2025; 9(1) doi: 10.1097/HC9.0000000000000628
|
| 12 |
Leona Radmanić, Petra Šimičić, Kristian Bodulić, Adriana Vince, Snjezana Zidovec-Lepej. Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C. Cytokine 2024; 176: 156529 doi: 10.1016/j.cyto.2024.156529
|
| 13 |
Sanad Dawod, Kimberly Brown. Non-invasive testing in metabolic dysfunction-associated steatotic liver disease. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1499013
|
| 14 |
Na‐Ling Kang, Ya‐Hong Gao, Meng‐Xin Lin, Lu‐Ying Wu, Xiang‐Yang Ye, Hui‐Ming Lin, Qing‐Fa Ruan, Shuo Lin, Hao‐Hang Liu, Ling‐Ling Huang, Jia‐Ji Jiang, Yu‐Rui Liu, Qi Zheng, Ri‐Cheng Mao, Da‐Wu Zeng. Development a novel nomogram model for predicting significant hepatic histological changes in chronic hepatitis B virus carriers. Journal of Medical Virology 2023; 95(7) doi: 10.1002/jmv.28943
|
| 15 |
Li-Yan Lin, Da-Wu Zeng, Yu-Rui Liu, Yue-Yong Zhu, Ling-Ling Huang. Diagnostic value of liver stiffness measurement combined with risk scores for esophagogastric variceal bleeding in patients with hepatitis B cirrhosis. European Journal of Radiology 2024; 173: 111385 doi: 10.1016/j.ejrad.2024.111385
|
| 16 |
Asgeir Johannessen, Dag Henrik Reikvam, Soo Aleman, Nega Berhe, Nina Weis, Hailemichael Desalegn, Tore Stenstad, Lars Heggelund, Ellen Samuelsen, Lars Normann Karlsen, Karin Lindahl, Frank Olav Pettersen, Jonas Iversen, Elisabeth Kleppa, Signe Bollerup, Anni Assing Winckelmann, Pascal Brugger‐Synnes, Hans Erling Simonsen, Jan Svendsen, Anne‐Marte Bakken Kran, Marte Holmberg, Inge Christoffer Olsen, Corina Silvia Rueegg, Olav Dalgard. Clinical trial: An open‐label, randomised trial of different re‐start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2024; 60(4): 434 doi: 10.1111/apt.18147
|
| 17 |
Kaiping Jiang, Lei Zhang, Jianhong Li, Hongtao Hu, Qinghua Huang, Tengyu Qiu, Xiaoai Mo, Jian Ren, Wenqiang Guo, Yin Tao, Haijun Cui, Ying Zuo, Xuli Chen, Youqing Xie, Yanxing Li, Haimin Liang, Zhaohong Liu, Le Xie, Rongjun Mao, Qunfang Jiang, Kaizhou Huang. Diagnostic efficacy of FibroScan for liver inflammation in patients with chronic hepatitis B: a single-center study with 1185 liver biopsies as controls. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02108-0
|
| 18 |
Dmitry V. Garbuzenko. Diagnostic and risk stratification aspects of liver fibrosis progression in chronic hepatitis B and C viral infection. Medical Journal of the Russian Federation 2021; 27(4): 373 doi: 10.17816/0869-2106-2021-27-4-373-384
|
| 19 |
Xian He, Ming-Xi Zhou, Cheng Cheng, Shan-Shan Li, Yuan Gao, Zhi-Tao Ma, Xin-Hua Song, Zhao-Fang Bai, Zheng-Sheng Zou, Xiao-He Xiao, Jia-Bo Wang, Ya-Wen Lu. Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.896198
|
| 20 |
Adam P. Buckholz, Robert S. Brown. Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats. Clinics in Liver Disease 2023; 27(1): 117 doi: 10.1016/j.cld.2022.08.008
|
| 21 |
Syed Ahmed, Sanchit Sharma, Samagra Agarwal, Yu Jun Wong, Martin Putera, Anoop Saraya. Utility of different Baveno criteria to detect esophageal varices irrespective of their size in patients with compensated cirrhosis. Indian Journal of Gastroenterology 2024; 43(3): 609 doi: 10.1007/s12664-023-01458-1
|
| 22 |
Daisuke Miura, Hiromi Suenaga, Kiyoshi Ichihara. The Utility of a Novel Stacked Microvascular Imaging for Enhanced Detection of Fibrosis in Chronic Liver Diseases. Ultrasound in Medicine & Biology 2024; 50(7): 975 doi: 10.1016/j.ultrasmedbio.2024.03.005
|
| 23 |
Chinmay Bera, Nashla Hamdan-Perez, Keyur Patel. Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients. Journal of Clinical Medicine 2024; 13(4): 1046 doi: 10.3390/jcm13041046
|
| 24 |
Antonio Liguori, Mirko Zoncapè, Giovanni Casazza, Philippa Easterbrook, Emmanuel A Tsochatzis. Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2025; 10(4): 332 doi: 10.1016/S2468-1253(24)00437-0
|
| 25 |
Mingwei Li, Mingjie Yao, Leijie Wang, Yanna Liu, Dong Ji, Yongping Yang, Fengmin Lu. The Early On-treatment Stiffness Decline Attributed to the Improved Hepatic Inflammation in Fibrotic Chronic Hepatitis B. Journal of Clinical Gastroenterology 2025; 59(5): 456 doi: 10.1097/MCG.0000000000002032
|